Managing EARLY-STAGE MYELOFIBROSIS via personalised clinical decision making tools and treatment
At the recent Malaysian Myeloproliferative Neoplasms (MPN) Expert Forum, Professor Martin Griesshammer from the Johannes Wesling University Hospital in Germany highlighted the role of personalised clinical decision-making tools and treatment in early-stage myelofibrosis. Chaired by Dr Alan Teh, Consultant Haematologist at Subang Jaya Medical Centre, the virtual forum was organised by Novartis, in collaboration with the Malaysian Society of Haematology (MSH).

New Molecule

5 New

New Indication

7 New

New Presentation

1 New

New Brand

15 New

Markings
Shape
Form
Color 1
Color 2
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in